Pharma companies are advancing critical care with innovative drugs, rare-disease research, and preventive diagnostics to address unmet needs.
Swine flu concerns are spreading from Delhi to Agra as Uttar Pradesh steps up surveillance, screening and hospital preparedness to track H1N1 cases.
The Novartis MS Pill, Rhapsido (remibrutinib), has cleared a major Phase 3 hurdle in relapsing multiple sclerosis (RMS). But the headline comes with an important clinical caveat. The Novartis MS pill significantly reduced annualized...
India's cancer challenge is growing, while breakthrough therapies today offer new hope for patients through earlier detection and innovation.
GSK is pushing its flu vaccine candidate into a crucial late-stage trial. The company plans to start a Phase III trial in September 2026. The move follows positive Phase II results for its mRNA flu vaccine candidate. The vaccine produced stronger...
Low-dose GLP-1 drugs can still help people lose weight, even when patients remain on the starter dose. However, the weight loss is much lower than results seen with higher doses.
Manipur Chief Minister Yumnam Khemchand Singh meets Union Health and Family Welfare Minister JP Nadda in New Delhi. During the discussion, Nadda agrees to upgrade the Regional Institute of Medical Sciences in Imphal to AIIMS
ICMR researchers reveal a clear mortality risk linked to drug-resistant infections in a major new study. The findings show these infections raise death rates, treatment costs, and hospital stays across Indian tertiary hospitals
The push to lower drug prices in America has gained momentum as Sun Pharma joins eight pharmaceutical companies in a new US pricing deal.
Autoimmune therapies, oncology advances, and major takeovers take center stage as three significant biologics deals reshape industry pipelines today
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")